Latest Insights & Developments

Unlock the full potential of IT in Pharma, MedTech, and Biotech commercialisation with AI-driven solutions. While much of life sciences tech focuses on drug development and compliance, a critical gap remains in go-to-market strategies, market access, and commercial execution. Legacy IT systems, fragmented data, and regulatory complexities slow down growth, but AI-powered automation is changing the game. Discover how Vamstar’s Polaris AI streamlines commercialisation by integrating market intelligence, pricing optimisation, and regulatory compliance tracking—driving faster, smarter decisions across 100+ markets. Read more to stay ahead in the evolving life sciences landscape.

Pharma is moving beyond traditional automation (DPA, RPA) towards agentic workflow management, powered by generative AI (genAI). Agentic AI offers autonomous adaptability across complex Pharma workflows—like regulatory compliance, clinical trials, and supply chain management. By blending agentic AI with existing systems, companies enhance efficiency and agility, as shown by Vamstar’s Mailbox Assistant, which streamlines bid management. This shift positions Pharma for a future of comprehensive, AI-driven automation, spanning every operational facet with precision and adaptability.

Discover how AI solutions from Vamstar can help pharmaceutical companies like Bristol Myers Squibb offset revenue losses due to loss of exclusivity (LoE). This article explores how Vamstar’s predictive market analytics, intelligent procurement tools, and portfolio optimization capabilities empower pharma firms to sustain growth, enhance strategic decisions, and remain competitive against generics. Learn how integrating AI tools can transform LoE challenges into opportunities for innovation and market expansion, as demonstrated by Bristol Myers Squibb’s proactive market strategies

Discover how AI is revolutionising the generics pharmaceutical industry with advanced pricing strategies. Vamstar's AI-driven Pricing Co-Pilot is setting new standards, transforming how companies approach tender pricing and bidding. Learn about the tangible benefits of integrating AI into your pricing processes, including improved accuracy, increased efficiency, and enhanced profitability. Embrace the future of pharma with AI-powered solutions that promise to refine decision-making and boost competitive advantage.

The danger of self-referential feedback loops—where AI systems endlessly recycle and distort data—is a significant concern. This phenomenon, often likened to a "fractal hall of mirrors," can lead to skewed outcomes and impaired decision-making. Vamstar AI, however, circumvents these risks through its meticulous data sourcing and processing protocols. By harnessing verified, closed industry sources, Vamstar ensures that the insights produced by its AI tools are both accurate and actionable, empowering businesses with reliable, data-driven strategies.

Discover how AI is revolutionising pharmaceutical manufacturing, from drug discovery to quality control. Learn about AI-driven tools like Vamstar's Tender AI, Pricing AI, and Value AI that streamline commercial operations, enhance market access, and empower pharmaceutical companies to stay competitive in an evolving industry. Explore the future of AI in pharma.

Leverage AI for healthcare tender management to enhance accuracy, streamline processes, and improve your bid success rates in the competitive MedTech sector.

Artificial Intelligence (AI) is emerging as a crucial enabler, particularly in the areas of tendering and Request for Proposal (RFP) management, where it is significantly enhancing efficiency and strategic decision-making.

The pharmaceutical industry in 2024 is experiencing transformative shifts, driven by AI innovations, biosimilars, and patient-centric care. Vamstar's AI tools like Tender AI and Pricing AI streamline commercial operations, enhancing market visibility and driving growth.

2024 Medtech Landscape in 2024: Leaders and Laggards: Innovation Key for Success. Discover who's leading and lagging behind, so far.

MedTech companies are grappling with inflation, driven by rising costs of materials, manufacturing, and logistics. Strategic price adjustments, cost management, value enhancement, and stakeholder collaboration are essential to counter these pressures. Vamstar's advanced price prediction and analytics tools help MedTech firms make informed decisions, maintain profitability, and foster long-term growth amid challenging economic conditions.

Discover how MedTech companies are strategically upskilling teams for AI adoption. Explore essential digital competencies, regulatory compliance, and commercial applications to drive innovation and competitive advantage in healthcare.

Join Vamstar at MedTech Forum 2025 in Lisbon to discover how AI-driven digital transformation is revolutionizing the MedTech industry and driving commercial innovation across Europe.

Pharma companies face the challenge of balancing cost efficiency with innovation in a competitive, highly regulated market. Smart cost management—through R&D optimisation, supply chain streamlining, and regulatory automation—is key to boosting profitability without compromising quality. AI, outsourcing, and sustainability unlock even greater efficiencies. Vamstar’s AI-powered solutions help pharma businesses cut costs, maximise savings, and make smarter strategic decisions for long-term growth.

Explore how drug manufacturers can navigate current market volatility driven by regulatory pressures, geopolitical tensions, and recession fears. Discover how leveraging AI-powered solutions can provide critical stability, enhancing sales forecasting, commercial efficiency, and market adaptability in uncertain economic times.